Am. J. Respir. Crit. Care Med., Volume 161, Number 4, April 2000, 1264-1273

Longitudinal Follow-up Study of Smoking-induced Lung Density Changes by High-resolution Computed Tomography

KENZO SOEJIMA, KAZUHIRO YAMAGUCHI, EIICHI KOHDA, KEI TAKESHITA, YOKO ITO, HIROAKI MASTUBARA, TSUYOSHI OGUMA, TAKASHI INOUE, YASUYUKI OKUBO, KAZUHISA AMAKAWA, HIROKI TATENO, and TETSUYA SHIOMI

Departments of Medicine and Radiology, School of Medicine, Keio University, Tokyo, Japan

To evaluate the ability of high-resolution computed tomography (HRCT) to detect longitudinal changes in structural abnormalities caused by smoking, HRCT and pulmonary function tests were used to examine nonsmokers, current smokers, and past smokers annually for 5 yr. Inspiratory HRCT was taken for the upper, middle, and lower lung fields, while expiratory images were obtained for the upper and lower lung fields only. We estimated the three quantitative CT parameters including MLD (mean CT value), HIST (CT value with the most frequent appearance), and %LAA (relative area of low attenuation with CT values less than 912 HU). Most of the pulmonary function tests, excepting FEV₁, did not change annually, whereas many of the inspiratory HRCT parameters did. In nonsmokers, only %LAA in the middle or lower lung fields exhibited an annual increase. In current smokers, %LAA in the upper lung field was augmented, while inspiratory MLD or HIST in the middle or lower lung field became more positive. In past smokers, %LAA in any lung field examined increased. The annual change in %LAA in the upper lung field was larger for past smokers than nonsmokers, with little difference between past and current smokers. Expiratory CT parameters showed few annual changes in all groups. In conclusion, (1) aging increases airspace abnormalities, mainly in the lower lung field; (2) although continuous smoking worsens airspace abnormalities mainly in the upper portion of the lung, this trend does not seem to slow down even after smoking cessation; and (3) inspiratory HRCT images are superior to expiratory images for longitudinal estimation of structural abnormalities caused by aging and smoking.

This article has been cited by other articles:

				L. Menchini, M. Remy-Jardin, J-B. Faivre, M-C. Copin, P. Ramon, R. Matran, V. Deken, A. Duhamel, and J. Remy Cryptogenic haemoptysis in smokers: angiography and results of embolisation in 35 patients Eur. Respir. J., November 1, 2009; 34(5): 1031 - 1039. [Abstract] [Full Text] [PDF]

				T. B. Grydeland, A. Dirksen, H. O. Coxson, S. G. Pillai, S. Sharma, G. E. Eide, A. Gulsvik, and P. S. Bakke Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking Eur. Respir. J., October 1, 2009; 34(4): 858 - 865. [Abstract] [Full Text] [PDF]

				C. J. McAloon, A. M. Wood, S. C. Gough, and R. A. Stockley Matrix metalloprotease polymorphisms are associated with gas transfer in alpha 1 antitrypsin deficiency Therapeutic Advances in Respiratory Disease, February 1, 2009; 3(1): 23 - 30. [Abstract] [PDF]

				B. C. Stoel, H. Putter, M. E. Bakker, A. Dirksen, R. A. Stockley, E. Piitulainen, E. W. Russi, D. Parr, S. B. Shaker, J. H. C. Reiber, et al. Volume Correction in Computed Tomography Densitometry for Follow-up Studies on Pulmonary Emphysema Proceedings of the ATS, December 15, 2008; 5(9): 919 - 924. [Abstract] [Full Text] [PDF]

				Chronic obstructive pulmonary disease: airways and systemic features Thorax, December 1, 2008; 63(Suppl_7): A135 - A138. [Full Text] [PDF]

				M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF]

				J. Holme and R. A. Stockley Radiologic and Clinical Features of COPD Patients With Discordant Pulmonary Physiology: Lessons From {alpha}1-Antitrypsin Deficiency Chest, September 1, 2007; 132(3): 909 - 915. [Abstract] [Full Text] [PDF]

				S. B. Fain, S. R. Panth, M. D. Evans, A. L. Wentland, J. H. Holmes, F. R. Korosec, M. J. O'Brien, H. Fountaine, and T. M. Grist Early Emphysematous Changes in Asymptomatic Smokers: Detection with 3He MR Imaging. Radiology, June 1, 2006; 239(3): 875 - 883. [Abstract] [Full Text] [PDF]

				E. J. Wagena, P. G. Knipschild, M. J. H. Huibers, E. F. M. Wouters, and C. P. van Schayck Efficacy of Bupropion and Nortriptyline for Smoking Cessation Among People at Risk for or With Chronic Obstructive Pulmonary Disease Arch Intern Med, October 24, 2005; 165(19): 2286 - 2292. [Abstract] [Full Text] [PDF]

				R A O'Donnell, C Peebles, J A Ward, A Daraker, G Angco, P Broberg, S Pierrou, J Lund, S T Holgate, D E Davies, et al. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD Thorax, October 1, 2004; 59(10): 837 - 842. [Abstract] [Full Text] [PDF]

				American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 818 - 900. [Full Text] [PDF]

				N Minematsu, H Nakamura, M Iwata, H Tateno, T Nakajima, S Takahashi, S Fujishima, and K Yamaguchi Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema Thorax, July 1, 2003; 58(7): 623 - 628. [Abstract] [Full Text] [PDF]

				M. Robin, P. Dong, C. Hermans, A. Bernard, A.D. Bersten, and I.R. Doyle Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects Eur. Respir. J., November 1, 2002; 20(5): 1152 - 1161. [Abstract] [Full Text] [PDF]

				J. H. Vernooy, M. Kucukaycan, J. A. Jacobs, N. H. Chavannes, W. A. Buurman, M. A. Dentener, and E. F. Wouters Local and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease: Soluble Tumor Necrosis Factor Receptors Are Increased in Sputum Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1218 - 1224. [Abstract] [Full Text] [PDF]

				K. Yamaguchi, K. Soejima, E. Koda, and N. Sugiyama Inhaling Gas With Different CT Densities Allows Detection of Abnormalities in the Lung Periphery of Patients With Smoking-Induced COPD Chest, December 1, 2001; 120(6): 1907 - 1916. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1789 - 1804. [Full Text] [PDF]

				F Mitsunobu, T Mifune, K Ashida, Y Hosaki, H Tsugeno, M Okamoto, S Harada, S Takata, and Y Tanizaki Influence of age and disease severity on high resolution CT lung densitometry in asthma Thorax, November 1, 2001; 56(11): 851 - 856. [Abstract] [Full Text] [PDF]

				A. Madani, C. Keyzer, and P.A. Gevenois Quantitative computed tomography assessment of lung structure and function in pulmonary emphysema Eur. Respir. J., October 1, 2001; 18(4): 720 - 730. [Abstract] [Full Text] [PDF]

				M.G. Cosio and G.L. Snider Chest computed tomography: is it ready for major studies of chronic obstructive pulmonary disease? Eur. Respir. J., June 1, 2001; 17(6): 1062 - 1064. [Full Text] [PDF]

				M. Remy-Jardin, J.-L. Edme, C. Boulenguez, J. Remy, I. Mastora, and A. Sobaszek Longitudinal Follow-up Study of Smoker's Lung with Thin-Section CT in Correlation with Pulmonary Function Tests Radiology, January 1, 2002; 222(1): 261 - 270. [Abstract] [Full Text] [PDF]